Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial-Reference-Cited by-同舟云学术

Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial

Published:2020-11 Issue: Volume:88 Page:106869
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Dastan Farzaneh,Saffaei Ali,Haseli Sara,Marjani Majid,Moniri Afshin,Abtahian Zahra,Abedini Atefeh,Kiani Arda,Seifi Sharareh,Jammati Hamidreza,Hashemian Seyed Mohammad Reza,Pourabdollah Toutkaboni Mihan,Eslaminejad Alireza,Heshmatnia Jalal,Sadeghi Mohsen,Nadji Seyed Alireza,Dastan Alireza,Baghaei Parvaneh,Varahram Mohammad,Yousefian Sahar,Salamzadeh Jamshid,Tabarsi Payam

Funder

Red Crescent Organization

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference29 articles.

1. Clinical characteristics of coronavirus disease 2019 in China;Guan;N. Engl. J. Med.,2020

2. COVID-19: consider cytokine storm syndromes and immunosuppression;Mehta;Lancet,2020

3. Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: a promising option for severe COVID-19;Dastan;J. Glob. Antimicrob. Resist,2020

4. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology;Channappanavar;Semin. Immunopathol..,2017

5. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease;McGonagle;Autoimmun. Rev.,2020

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of dolutegravir in moderate severity COVID-19 patients: A single-center, randomized, double-blind, placebo-controlled trial;BioImpacts;2024-06-26

2. Preclinical and Clinical Investigations of Potential Drugs and Vaccines for COVID-19 Therapy: A Comprehensive Review With Recent Update;Clinical Pathology;2024-01

3. Review of Covid-19's Current Development in Therapeutic and Diagnostic Techniques;Biosciences Biotechnology Research Asia;2023-12-31

4. Does tocilizumab have an effect on the clinical outcomes in COVID-19 patients? A meta-analysis of randomized control trials;Journal of Pharmaceutical Policy and Practice;2023-11-20

5. The effects of combination-therapy of tocilizumab and baricitinib on the management of severe COVID-19 cases: a randomized open-label clinical trial;Frontiers in Pharmacology;2023-10-19